Medicine and Dentistry
Surgery
100%
Aortic Dissection
69%
Non Small Cell Lung Cancer
68%
Lung Cancer
66%
Neoplasm
41%
Endovascular Aneurysm Repair
34%
Overall Survival
34%
Lobectomy
33%
Lung
33%
Thrombosis
32%
Pneumonectomy
32%
Thoracic Aorta
30%
Computer Assisted Tomography
27%
Aneurysm
26%
Disease
24%
Mesenchymal Stem Cell
23%
Recurrent Disease
23%
Recurrence Free Survival
22%
off Pump Coronary Surgery
22%
Prognostic Factor
20%
Monocrotaline-Induced Pulmonary Hypertension
20%
Malignant Neoplasm
18%
Cord Blood
17%
Abdominal Aorta
17%
Hospital Mortality
17%
Lung Function
17%
Interleukin 6
17%
Cancer Surgery
16%
Monocrotaline
16%
Gene Expression
16%
Survival Rate
16%
Hazard Ratio
15%
In Vitro
14%
Pulmonary Hypertension
14%
Lymph Node
14%
Tumor Necrosis Factor
14%
Pulmonary Artery
14%
Neurinoma
14%
Chemoradiotherapy
14%
Celiac Artery
13%
Aortic Arch
13%
Lymph Node Metastasis
12%
Artery
12%
Video-Assisted Thoracoscopic Surgery
12%
Prevalence
12%
Metastatic Carcinoma
12%
Endothelial Nitric Oxide Synthase
11%
Epithelioma
11%
Caspase 3
11%
Endothelin 1
11%
B Cell Leukemia
11%
Descending Aorta
11%
Esophageal Cancer
11%
Surgical Anastomosis
10%
Lung Lobectomy
10%
Esophageal Squamous Cell Carcinoma
10%
Hematoma
10%
Clinical Stage
10%
Esophagectomy
10%
Retroperitoneal Lymph Node Dissection
10%
Programmed Cell Death
9%
Thoracotomy
9%
Odds Ratio
9%
Stent-Graft
9%
Ascending Aorta
9%
Brain Perfusion
9%
Hemodynamic
9%
Suture
9%
Gelatinase A
8%
Left Subclavian Artery
8%
Protein Expression
8%
Forced Expiratory Volume
8%
Thromboembolism
8%
Heart Arrest
8%
Elderly Patient
8%
Saphenous Vein
8%
Chronic Obstructive Pulmonary Disease
8%
Retrospective Study
8%
Prosthesis
8%
Atrial Fibrillation
7%
Mortality Rate
7%
Emphysema
7%
Receptor
7%
Observational Study
7%
Squamous Cell Carcinoma
7%
Surgical Mortality
7%
Pneumothorax
7%
Phase II Trials
7%
Vascular Endothelial Cell
7%
Endothelial Cell
7%
Airflow
7%
Vasculotropin
7%
Fontan Procedure
7%
Sarcomatoid
7%
Lung Adenocarcinoma
7%
Epidermal Growth Factor Receptor
7%
Breast Cancer
7%
Xenograft
7%
Mesothelioma
7%
Mitral Valve Disease
7%
Pharmacology, Toxicology and Pharmaceutical Science
Rat Model
69%
Monocrotaline
57%
Monocrotaline-Induced Pulmonary Hypertension
56%
Pulmonary Hypertension
41%
Endothelial Nitric Oxide Synthase
33%
Endothelin 1
29%
Tumor Necrosis Factor
27%
Endothelin A Receptor
24%
Interleukin 6
21%
Non Small Cell Lung Cancer
21%
Bosentan
17%
Losartan
17%
Caspase 3
16%
Gelatinase A
15%
Overall Survival
15%
Neoplasm
14%
Spontaneously Hypertensive Rat
14%
Brain Natriuretic Peptide
14%
Inflammation
14%
B Cell Leukemia
13%
Disease
13%
Messenger RNA
13%
Vasculotropin
11%
Subcutaneous Injection
11%
Doxorubicin
10%
Lung Cancer
10%
Modafinil
10%
Myocardial Disease
10%
Recurrent Disease
10%
Heart Right Ventricle Failure
9%
Receptor
9%
Matrix Metalloproteinase
9%
Lymph Node Metastasis
9%
Mouse Model
8%
Recurrence Free Survival
8%
Western Blot
7%
Endothelin Receptor
7%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase 4
7%
Heart Arrest
7%
Cancer Growth Factor
7%
Aneurysm
7%
Fibrinogen
7%
Squamous Cell Lung Carcinoma
7%
Endothelin Converting Enzyme
7%
Persistent Atrial Fibrillation
7%
Short Hairpin RNA
7%
Phase II Trials
7%
Docetaxel
7%
Lung Adenocarcinoma
7%
Mitral Valve Disease
7%
Cisplatin
7%
Epithelium Tumor
7%
Shoulder Pain
7%
Tumor Classification
7%
Ambrisentan
7%
Atrial Fibrillation
7%
Epidermal Growth Factor Receptor
7%
Infliximab
7%
Ranolazine
7%
Simvastatin
7%
Monocyte Chemotactic Protein 1
7%
Aortic Aneurysm
7%
Lung Embolism
7%
Matrigel
7%
Thrombosis
6%
Sprague Dawley Rat
6%
Survival Rate
6%
Atherosclerosis
5%
Tissue Inhibitor of Metalloproteinase 2
5%
Prevalence
5%